EXPERIMENTAL AND CLINICAL BARBITURATE ANTAGONISM. 1964

G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT

UI MeSH Term Description Entries
D010424 Pentobarbital A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) Mebubarbital,Mebumal,Diabutal,Etaminal,Ethaminal,Nembutal,Pentobarbital Sodium,Pentobarbital, Monosodium Salt,Pentobarbitone,Sagatal,Monosodium Salt Pentobarbital
D010433 Pentylenetetrazole A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. Leptazole,Pentamethylenetetrazole,Pentetrazole,Cardiazol,Corasol,Corazol,Corazole,Korazol,Korazole,Metrazol,Metrazole,Pentazol,Pentylenetetrazol
D010600 Pharmacology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. Pharmacologies
D010852 Picrotoxin A mixture of PICROTOXININ and PICROTIN that is a noncompetitive antagonist at GABA-A receptors acting as a convulsant. Picrotoxin blocks the GAMMA-AMINOBUTYRIC ACID-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and an antidote in poisoning by CNS depressants, especially the barbiturates. 3,6-Methano-8H-1,5,7-trioxacyclopenta(ij)cycloprop(a)azulene-4,8(3H)-dione, hexahydro-2a-hydroxy-9-(1-hydroxy-1-methylethyl)-8b-methyl-, (1aR-(1aalpha,2abeta,3beta,6beta,6abeta,8aS*,8bbeta,9S*))-, compd. with (1aR-(1aalpha,2abeta,3beta,6beta,6abeta,8,Cocculin
D011277 Pregnanediones Pregnane derivatives in which two side-chain methyl groups or two methylene groups in the ring skeleton (or a combination thereof) have been oxidized to keto groups. Diketopregnanes,Dioxopregnanes
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D001463 Barbiturates A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.
D001534 Bemegride A CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose. Ethylmethylglutarimide,Methetharimide,Megimide
D014116 Toxicology The science concerned with the detection, chemical composition, and biological action of toxic substances or poisons and the treatment and prevention of toxic manifestations. Toxinology,Evidence Based Toxicology,Evidence-Based Toxicology,Based Toxicologies, Evidence,Based Toxicology, Evidence,Evidence Based Toxicologies,Evidence-Based Toxicologies,Toxicologies, Evidence Based,Toxicologies, Evidence-Based,Toxicology, Evidence Based,Toxicology, Evidence-Based
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT
August 1954, Nature,
G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT
November 1954, Comptes rendus des seances de la Societe de biologie et de ses filiales,
G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT
May 1976, Anesthesiology,
G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT
January 1946, Federation proceedings,
G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT
December 1955, Medizinische Klinik,
G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT
July 1946, The Journal of pharmacology and experimental therapeutics,
G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT
May 1946, The Journal of pharmacology and experimental therapeutics,
G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT
March 1967, Epilepsia,
G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT
October 1935, Science (New York, N.Y.),
G M LAYCOCK, and K H SHANKLY, and A SHULMAN, and R D WRIGHT
November 1975, Archives internationales de pharmacodynamie et de therapie,
Copied contents to your clipboard!